How realistic is Will Halstead’s drug trials drama?


Chicago Med Season 6 focused part of Season 6 on Will Halstead and his unethical handling of the drug trial. So much went wrong under his watch that it’s surprising he wasn’t fired earlier in the season. And Natalie Manning (Torrey DeVitto) didn’t help much either. She found a way to mix her personal drama with Will’s drama, and things just turned into a mess.

How realistic were the events that occurred? Showbiz Cheat Sheet met Courtney Valeo, Senior Senior Consultant at Greenphire, a provider of financial lifecycle management solutions for clinical trials. Here’s what she had to say about Chicago Med.

What would happen to Will in real life?

Nick Gehlfuss as Dr Will Halstead in “Chicago Med”. | Adrian S Burrows Sr./NBC/NBCU Photo Bank via Getty Images

Will often makes up the rules as he goes along. His behavior was no different during the clinical trial. Will did what he wanted. What would happen if he behaved this way in real life? Valeo claims that this behavior would have serious consequences in the real world.

“In real life, stealing a drug would end a career,” says Valeo. “This could potentially compromise study data and, more importantly, potentially put patients at risk.”

How realistic is the situation with Dr Will Halstead on ‘Chicago Med’?

Will Halstead did not follow the rules of

Will Halstead did not follow the rules of “Chicago Med”. How realistic is his drug trial drama? | Elizabeth Sisson / NBC / NBCU Photo Bank via Getty Images

Is Will Halstead’s situation realistic? Is it Really Possible to Slip Test Drugs to a Patient who is Not in a Trial? Everything is possible, but it is not probable. Valeo says this scenario is unrealistic.

“Like many other medical dramas, this storyline is entertaining but above all unrealistic,” Greenphire’s Vaelo told Showbiz Cheat Sheet. “The overall clinical trial process, including what to do with unused study drugs, is set by the Food and Drug Administration with checks and balances in place. Very detailed records are kept. , and if the research site has any leftover products, these are usually destroyed or returned to the study sponsor. It is possible, though incredibly unlikely and illegal, that additional experimental drugs will end up being administered to a patient not registered for a trial. “

‘Chicago Med’ sheds light on racial bias in clinical trials

Yaya DaCosta as April Sexton and Nick Gehlfuss as Dr Will Halstead in 'Chicago Med'

Yaya DaCosta as April Sexton and Nick Gehlfuss as Dr Will Halstead in ‘Chicago Med’ | Elizabeth Sisson / NBC / NBCU Photo Bank via Getty Images

Valeo tells Showbiz Cheat Sheet that part of the Chicago Med scenario that was realistic was the depiction of racial bias in drug trials.

Diversity in clinical trials has become a hotly debated and very important topic, especially as a result of the health disparities we have seen throughout the pandemic, ”said Valeo. “In November 2020, the FDA released official guidelines for the clinical trials industry to structure and administer clinical trials to take into account racial biases found in the system.”

Valeo says Chicago Med does a good job of demonstrating the need for diversity in drug trials. “In one episode, an African-American man walks into the emergency room and is diagnosed with heart failure. However, he does not qualify for the trial because the serum creatinine levels in his body are just above the eligibility threshold. April (Yaya DaCosta) tells Will that black men often have higher serum creatinine even in good health.

At first, Will doesn’t see April’s side and rejects his conclusions. “Will says these limits are very strict in order to ‘protect the data’, explains Valeo. “This leads April to comment that while black Americans are 30% more likely to die from heart failure than average, only 3% of patients enrolled in this clinical trial are black. Eventually, Will finds a way to get around these rules (as he’s known to do) so the drug can be administered. But these types of bias in testing are unfortunately common. “

Follow Sheiresa Ngo on Twitter.